In MYCN-amplified neuroblastoma, cells predominantly rely on activation of ASCT2 (solute carrier family 1 member 5, SLC1A5) to maintain sufficient levels of glutamine essential for the TCA cycle anaplerosis 25, 26. The gene discussed is SLC1A5; the disease is neuroblastoma.